Soonchunhyang Med Sci.  2020 Dec;26(2):127-130. 10.15746/sms.20.031.

Extracorporeal Membrane Oxygenation Treatment in Coronavirus Disease 2019: Two Cases

Affiliations
  • 1Department of Thoracic and Cardiovascular Surgery, Soonchunhyang University Bucheon Hospital, Bucheon, Korea

Abstract

Among the clinical symptoms of coronavirus disease 2019 (COVID-19), acute respiratory dysfunction syndrome (ARDS) is the most rapid and fatal form of clinical symptoms, and since conventional treatment cannot achieve satisfactory results, extracorporeal membrane oxygenation (ECMO) can be tried. We report two cases, one of the COVID-19 patients who received ECMO treatment for ARDS at Soonchunhyang University Bucheon Hospital received long-term ECMO treatment but improved without any complications, and one patient who received ECMO treatment for viral myocarditis rapidly deteriorated and died. We describe ECMO treatment in COVID-19 through the two cases mentioned above.

Keyword

COVID-19; Extracorporeal membrane oxygenation; Acute respiratory dysfunction syndrome; Myocarditis
Full Text Links
  • SMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error